Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Anagenics ( (AU:AN1) ) has issued an update.
Anagenics Limited has announced a two-tranche placement to raise A$2.25 million by issuing approximately 489 million new shares at $0.0046 each, an 8% discount to the recent average price. The funds will support brand expansion, new business opportunities, debt reduction, and working capital. The placement, involving institutional and sophisticated investors, will occur in two stages, with the second tranche subject to shareholder approval. This strategic move aims to strengthen Anagenics’ market position and operational capabilities.
More about Anagenics
Anagenics Limited is a health, beauty, and wellness company that enhances shareholder value through the global distribution and sales of its proprietary and licensed brands. The company specializes in differentiated, clinically validated anti-aging solutions and operates BLC Cosmetics Pty Ltd, a wholly owned subsidiary focused on distributing leading Australian and international cosmetic and wellness brands.
Current Market Cap: A$2.48M
See more data about AN1 stock on TipRanks’ Stock Analysis page.